Team:UCSD Software/Attributions
From 2014.igem.org
(Difference between revisions)
Line 452: | Line 452: | ||
- | <!-- START | + | <!-- START SYNTHETIC GENOMICS --> |
<div class="row marketing"> | <div class="row marketing"> | ||
<div class="col-lg-3"> | <div class="col-lg-3"> | ||
- | <img src = " | + | <img src = "http://nextgenseek.com/wp-content/uploads/2012/02/SyntheticGenomicsIncLogo.jpg" width = "150px" height = "175px" style = "border-radius: 5px 20px 5px;"> |
</div> | </div> | ||
<div class="col-lg-9"> | <div class="col-lg-9"> | ||
- | <h4> | + | <h4>Synthetic Genomics</h4> |
- | <p> | + | <p>Synthetic Genomics Inc. was founded to commercialize genomic-driven technologies. Our scientific strength lies in the decades of pioneering research by founders, J. Craig Venter, Ph.D., Nobel Laureate Hamilton O. Smith, M.D., and the leading scientific teams they have assembled. Dr. Venter and his teams have proven track records of making scientific breakthroughs that translate into viable commercial solutions. We would like to extend our heartfelt gratitude to them for supporting our team at iGEM 2014.</p> |
</div> | </div> | ||
</div> | </div> | ||
- | <!-- END | + | <!-- END SYNTHETIC GENOMICS--> |
Revision as of 08:52, 13 October 2014
Synthetic Genomics
Synthetic Genomics Inc. was founded to commercialize genomic-driven technologies. Our scientific strength lies in the decades of pioneering research by founders, J. Craig Venter, Ph.D., Nobel Laureate Hamilton O. Smith, M.D., and the leading scientific teams they have assembled. Dr. Venter and his teams have proven track records of making scientific breakthroughs that translate into viable commercial solutions. We would like to extend our heartfelt gratitude to them for supporting our team at iGEM 2014.